Alcohol Tobacco & Other Drug Research Unit, Medical Research Council, South Africa; School of Public Health, University of Cape Town, South Africa.
Alcohol Tobacco & Other Drug Research Unit, Medical Research Council, South Africa.
Int J Drug Policy. 2020 Sep;83:102839. doi: 10.1016/j.drugpo.2020.102839. Epub 2020 Jul 7.
South Africa has seen a sharp increase in treatment admission trends for opioids despite beliefs that rates of opioid use remain low and do not represent a major problem. To advocate for the extension of Opioid Use Disorder (OUD) treatment and harm minimisation services in South Africa, better estimates of the extent of opioid use is needed. This paper responds to this need by describing (i) trends in treatment utilization for opioid-related problems in South Africa and (ii) differences in the profile of patients accessing treatment for different classes of opioids - heroin, 'nyaope' and codeine use.
Data were collected from 83 specialist treatment centres participating in the South African Community Epidemiology Network on Drug Use between 2012 and 2017. Descriptive analyses were conducted to describe the sociodemographic profile of patients and multiple logistic regression was used to explore socio-demographic and clinical factors associated with admission to treatment for opioid use disorders (OUD) .
From January 2012 to December 2017, data from 11 2032 treatment episodes were collated. Of these, 20 319 (18.1%) were from patients admitted for an OUD. Over time, the proportion of overall opioid-related admissions increased significantly from 16.1% of all admissions in 2012 to 20.0% in 2017 (p <0.001). Data also suggests a significant increase in the overall proportion of patients reporting injection drug use, from 1.6% in 2013 to 3.5% in 2017 (p <0.001). Clear differences in employment status, referral sources between classes of opioids were also noted.
Over the last 5 years, South Africa has seen an increase in the proportion of opioid related disorders (OUD) treatment admissions. Public health interventions, evidence-based harm reduction approaches and improving access to treatment are among the interventions urgently needed to reduce the harms associated with the increased use of opioids in South Africa.
尽管南非的阿片类药物使用率较低,且不构成主要问题,但人们认为阿片类药物的治疗入院率呈急剧上升趋势。为了倡导在南非扩大阿片类药物使用障碍(OUD)治疗和减少伤害服务,需要更好地估计阿片类药物使用的程度。本文通过描述南非治疗利用阿片类药物相关问题的趋势和不同类别的阿片类药物(海洛因、“nyaope”和可待因)治疗患者的特征差异,来满足这一需求。
本研究数据来自于 2012 年至 2017 年参与南非社区药物使用流行病学网络的 83 个专科治疗中心。采用描述性分析来描述患者的社会人口学特征,并用多因素逻辑回归来探讨与阿片类药物使用障碍(OUD)治疗入院相关的社会人口学和临床因素。
2012 年 1 月至 2017 年 12 月,共收集了 112032 例治疗记录。其中,20319 例(18.1%)是因 OUD 而入院。随着时间的推移,总的阿片类药物相关入院比例从 2012 年所有入院的 16.1%显著增加到 2017 年的 20.0%(p <0.001)。数据还表明,报告注射吸毒的患者比例也从 2013 年的 1.6%显著增加到 2017 年的 3.5%(p <0.001)。此外,还注意到不同类别的阿片类药物之间在就业状况和转诊来源方面存在显著差异。
在过去的 5 年里,南非因阿片类药物相关障碍(OUD)而接受治疗的比例有所增加。公共卫生干预措施、循证减少伤害方法和改善治疗机会等干预措施是减少南非阿片类药物使用增加所带来危害的紧急需要。